Intuitive Surgical, Inc. vs Levi Strauss & Co. — how do they compare? Intuitive Surgical, Inc. trades at $400 (market cap $138.97B), while Levi Strauss & Co. trades at $22.84 (market cap $9.09B). The key difference: Intuitive Surgical, Inc. is far larger — about 15.3× Levi Strauss & Co.'s market cap, and Levi Strauss & Co. pays a 2.71% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | LEVI | |
|---|---|---|
Market Cap | $138.97B | $9.09B |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $25.53 |
52-Week Low | $332.02 | $17.92 |
Enterprise Value | $133.76B | $10.40B |
Dividend Yield | — | 2.71% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $378.81, up 1.36% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bullish technical signals despite premium valuations (P/E 43.44, P/S 12.35), supported by robust revenue growth reaching $10.06B in 2025 and expanding profit margins of 28.45%. Recent news highlights da Vinci 5 adoption driving procedure growth beyond urology.
Outlook remains positive with 68% analyst buy ratings and $519.05 price target suggesting 37% upside. Key risks include competitive pressure from Medtronic/J&J robots and potential U.S. procedure softness. The combination of durable demand and innovation pipeline supports long-term growth potential for MedTech investors.
Levi Strauss (LEVI) trades at $24.4, up 0.39% on the day, with a bullish fundamental backdrop including strong earnings beats and a 77.78% analyst buy rating. The stock shows a bearish technical signal overall, with neutral RSI readings and key resistance at $25. Recent news highlights a cybersecurity breach disclosed on August 7, 2026, but the company's direct-to-consumer digital strategy continues to drive growth.
Outlook remains positive with a consensus price target of $27.88, implying 14.3% upside, supported by robust profitability and raised 2026 guidance. Risks include recent cybersecurity issues, tariff pressures, and execution challenges in a competitive apparel market.
Trailing returns across standard periods
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →